Uso de agente paralisante da função neuromuscular aplicado no tratamento de comorbidades relacionadas à região de cabeça e pescoço de pacientes atendidos do Humap-UFMS/EBSERH, a partir do emprego da Toxina Botulínica Tipo A (TBA)

Abstract

Demand submitted by the Head and Neck Unit UCA/DGC/GAS/Humap-UFMS to the Center for Health Technology Assessment (NATS) at the Maria Aparecida Pedrossian University Hospital HumapUFMS/Ebserh for the use of a neuromuscular function paralyzing agent applied in the treatment of comorbidities related to the head and neck region of patients treated at Humap-UFMS/EBSERH, from use of Botulinum Toxin Type A (TBA). Obtained in the laboratory, TBA is a biological agent, with a stable crystalline appearance, lyophilized in human albumin, preserved in a sterile vacuum flask, with dilution in saline solution. Of eight serological types of toxin produced by the anaerobic bacterium, Clostridium botulinum, the most potent is type A, which is of clinical use (SPOSITO, 2004).